FNY Investment Advisers’s Soleno Therapeutics SLNO Stock Holding History

FNY Investment Advisers’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$1K	–	1424
2025 Q3	$1K	Buy	+25	New	+$1.85K	﹤0.01%	1185

FNY Investment Advisers's SLNO Position: Q2 2026 in Review

FNY Investment Advisers sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 3,500 shares — an estimated $117K sold.

FNY Investment Advisers first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $162K in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

FNY Investment Advisers reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
FNY Investment Advisers sold 3,500 Soleno Therapeutics shares in Q2 2026, an estimated $117K.
FNY Investment Advisers first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
FNY Investment Advisers's Soleno Therapeutics position peaked at $162K in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.